dementias Flashcards

1
Q

what defines dementia?

A

Syndrome which refers to progressive decline in intellectual functioning (COGNITION), severe enough to interfere with person’s normal daily activities and social relationships.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dementia mainly affects people over the age of ___________and the likelihood increases with age

A

Dementia mainly affects people over the age of 65 and the likelihood increases with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the most prevalent forms of dementia?

A

Alzheimer’s Disease
Vascular Dementia
Lewy Body Dementia
Frontotemporal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the rarer forms of demetia

A

Pre-senile Dementia
Picks Disease
Korsakov Dementia*
Pseudo-dementia*
Endocrine related Dementia*
Parkinson’s Disease
Huntington’s chorea
Posterior cortical atrophy
Normal Pressure Hydrocephalus*
Neurosyphilis*
* are reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

features of vascular dementia?

Refers to the____________
Early symptoms are ___________ and _________
Often a history of ____________
Stepwise progression
Vascular risk factors usually present (_______, _________, __________)

A

Refers to the pathology – many different types
Early symptoms are memory difficulties and executive difficulties
Often history of stroke / falls
Stepwise progression
Vascular risk factors usually present (High blood pressure, high cholesterol, diabetes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

features of Lewy body dementia?

Under the umbrella of disease related to _______________
Early symptoms include ________________

A

Under the umbrella of disease related to Parkinson’s disease
Early symptoms include executive difficulties
Visuospatial problems
Hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

features of frontotemporal demetia?

A

______frontotemporal______variant
Umbrella term – may different variants including ____picks____, ____semantic ____, _primary progressive aphasia________
The main cognitive deficits are in executive ______difficulties______ and____attention________
____Visuospatial______and _____memory_____abilities mostly spared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the Changes in Cognitive Symptoms with Dementia? in relation to perception

PERCEPTION 🡺 the process of making sense of information externally (environment) and internally (your body)

A

Unable to recognize objects
Unable to judge the position/ location of people/ objects.
Ignoring one side of the world (including oneself, environment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the Changes in Cognitive Symptoms with Dementia? in relation to EXECUTIVE FUNCTIONING

EXECUTIVE FUNCTIONING 🡺 processing of information in order to plan, sequence, make decisions, prioritize, problem-solve and self-monitor

A

Difficulties with initiating tasks
Getting stuck on tasks/ repeating actions
Not thinking through the consequences of actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the Changes in Cognitive Symptoms with Dementia? in relation to LANGUAGE

LANGUAGE 🡺 understanding information said by others (receptive language) and the process of expressing information (expressive language)

A

Difficulties understanding (e.g. words, concepts, complex sentences)
Difficulties finding the word
Reduced vocabulary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

symptoms of Non-cognitive dementia?

A

Apathy / Indifference

Disinhibition

Irritability / lability / aggression

Aberrant motor behaviour

Night-time behaviour

Appetite / Eating change

Delusions

Hallucination

Agitation / wandering

Depression / dysphoria

Anxiety

Euphoria/elation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For complete diagnosis of dementia, patients need to show?

A

Memory impairment
Impairment in one or more of the following cognitive domains (language; motor activity; recognition; executive function)
Continuing cognitive decline
Clinically, one cannot conclusively determine the subtype of Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A range of diagnostic criteria involving different healthcare practitioners

what are they?

A

Mini Mental State Exam (MMSE)
A series of questions and tests
Tests a number of different mental abilities (memory, attention and language).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens in alzheimer’s pathology

A

Neurofibrillary tangles: rich in cytoskeletal proteins, especially the microtubule-associated protein, “tau”.
In the tangles: heavily phosphorylated proteins,
which may cause aggregation and precipitation of the cytoskeleton.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the two major hypotheses for AD

β amyloid protein (BAP) v. tau

A

BAPtists: The accumulation of a fragment of the amyloid precursor protein or APP (the amyloid beta 42 residue fragment or
Ab-42) leads to the formation of plaques that kills neurons.

TAUists: Abnormal phosphorylation of tau proteins makes them “sticky,” leading to the break up of microtubules. The resulting
loss of axonal transport causes cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DESCRIBE THE AMYLOID HYPOTHESIS?

A

The amyloid precursor protein (APP) is broken down by a series of secretases.

During this process, a non-soluble fragment of the APP protein (called Aβ-42) accumulates and is deposited outside the cell.

The non-soluble or “sticky” nature of Aβ-42 helps other protein fragments
(including apoE) to gather into plaques.

Somehow the plaques (or possible the migration of Aβ-42 outside the
cell) cause neuronal death.

17
Q

in TAU hypothesis:

Neurons have an _________structure partly made up of microtubules. A protein called ________ helps stabilize microtubules. In AD, _________ changes, causing microtubules to _______, and ________ proteins clump together to form neurofibrillary tangles.

A

Neurons have an internal support structure partly made up of microtubules. A protein called tau helps stabilize microtubules. In AD, tau changes, causing microtubules to collapse, and tau proteins clump together to form neurofibrillary tangles.

18
Q

describe the TAU hypothesis?

A

Ordinarily, the τ (tau) protein is a microtubule-associated protein that
acts as a three-dimensional “railroad tie” for the microtubule. The microtubule is responsible for axonal transport.

Accumulation of phosphate on the tau proteins cause “paired helical
filaments” or PHFs (like two ropes twisted around each other) that accumulate and lead to the neurofibrillary tangles (NFT). PHFs are the
main component in NFTs.

Impaired axonal transport is the probable cause of cell death.

19
Q

what are the current theories for AD

A

Multifactorial, involving several pathways and dependent on life experience 🡺 not all old people get AD

Protein accumulation 🡺 plaques & tangles 🡺 does not explain all the pathology
Inflammation🡺 overactive brain immune cells (microglia)
Oxidative stress 🡺 development of free radicles 🡺 cellular death

20
Q

what is the features of the first stage of Alzheimer’s disease

A

Synapse loss occurs first, then neurons die
Changes can begin 10-20 years before symptoms
appear.

Primary early symptom 🡺 deficit in recent memory
Intellectual deficits confirmed by neuropsychological
testing
Some awareness of their symptoms, so the person
may become anxious, depressed and may be in denial
No distinguishing features on physical examination

21
Q

state features of the second stage of Alzheimer’s disease?

A

AD pathology (Tau and Aβ) spreads through the brain.
The cerebral cortex begins to shrink as more neurons die.

Significant memory loss (forget close family members
well known routes/places)
🡺 Personality and behavioural changes (self-neglect
🡺 Disorientation in time and space
Inability to undertake simple tasks i.e. dressing
🡺 Reduced range of thinking (intellectual deficits)
🡺 Language problems start

22
Q

state features of the 3rd stage of Alzheimer’s disease?

A

Extreme shrinkage occurs in the brain
Patients are completely dependent on others for care.

🡺Dysphasia with disordered and fragmented
speech
🡺Aggression, restlessness and wandering
🡺Hallucinations and delusions
🡺Incontinence
🡺Immobility, rigidity and recurrent falls
🡺General physical deterioration

Death usually occurs from aspiration
pneumonia or other infections.

23
Q

what are the pharmacotherapeutic approaches for treating AD?

A

Acetylcholinesterase inhibitors

Glutamate NMDA receptor antagonist

24
Q

explain why Acetylcholinesterase inhibitors
are used for AD, and what are the examples

A

Cholinergic basal forebrain neurons are among the first to die in AD resulting in decreased brain levels of Ach
🡺 Tacrine, Donepezil, Rivastigimine, Galantamine

25
Q

explain why Glutamate NMDA receptor antagonist
are used for AD, and what are the examples

A

Excitotoxicity (overactvity of glutamatergic synapses) proposed to be part of AD pathology)
🡺 Memantine

26
Q

what DRUG CLASS is the first line treatment for AD and what does it improve?

A

Acetylcholinesterase inhibitors

🡺Cognitive function
🡺Behavioural symptoms
🡺Daily activities

27
Q

which Acetylcholinesterase inhibitor was the first drug to have any therapeutic effect

A

Tacrine

28
Q

what is the moa for Tacrine and what are the side effects?

A

MOA
Long acting AchEI
Blocks M1, M2 and nicotinic receptors
Increases the release of Ach from nerve endings
Inhibit MAO
Increase release of NA, 5HT and DA from nerve endings

SIDE EFFECTS (SIGNIFICANT)
Nausea and vomiting - increased peripheral Ach levels
Hepatic toxicity - life threatening
- Largely superseded by newer AchEIs

29
Q

what are the Acetylcholinesterase inhibitors for AD treatment?

A

Donepezil, Tacrine, Rivastigimine, Galantamine

30
Q

what is the moa for donepezil and what are the indication and side effects ?

A

Indicated for the treatment of mild-to-moderate AD, but can be used for moderate-to-severe AD
Modest improvements in cognitive and behavioural scores in AD patients

MOA
Reversible centrally active AchEI

SIDE EFFECTS
Nausea and vomiting
Hallucinations, Aggression, Agitation
Urinary incontinence
Gastric and duodenal ulcers